| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| nicardipine | alpha-1a adrenergic receptor | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| nicardipine | alpha-1b adrenergic receptor | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| nicardipine | alpha-1d adrenergic receptor | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| nicardipine | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.37 | approved,investigational | inhibitor |
| nicardipine | voltage-dependent l-type calcium channel subunit alpha-1d | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| nicardipine | voltage-dependent calcium channel subunit alpha-2/delta-1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| nicardipine | voltage-dependent l-type calcium channel subunit beta-2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| nicardipine | calmodulin | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| nicardipine | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| nicardipine | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| nicardipine | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| nicardipine | muscarinic acetylcholine receptor m4 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| nicardipine | muscarinic acetylcholine receptor m5 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | antagonist |
| nicardipine | calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1a | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| nicardipine | calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1b | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Stable angina[MeSHID:D060050] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||